XPENG Reports Strong Vehicle Delivery Growth for Q3 2026
XPENG Inc. announces increased vehicle deliveries for September and Q3 2026, showcasing growth in the electric vehicle market.
Korea Electric Power clarifies merger rumors in SEC filing
Korea Electric Power Corp clarifies media reports on a potential merger of its subsidiaries, signaling ongoing restructuring in the electric services industry.
Taylor Devices reports Q1 results for fiscal year 2027
Taylor Devices, Inc. has released its Q1 2027 financial results, highlighting key metrics and performance insights in the industrial machinery sector.
Phaos Technology Holdings Announces 1-for-15 Reverse Stock Split
Phaos Technology Holdings will execute a 1-for-15 reverse stock split effective October 12, 2026, aimed at enhancing its market presence.
PT Telekomunikasi Indonesia Announces Share Buyback Plan
PT Telekomunikasi Indonesia Tbk reveals a share buyback plan to enhance shareholder value, aligning with regulatory changes in the telecommunications sector.
Ballard Power Systems Launches Fleet360 Services at APTA EXPO
Ballard Power Systems introduces Fleet360 services, enhancing support for fuel cell technology at APTA EXPO 2026, aiming to boost reliability and lifecycle management.
Ryanair Reports 4% Increase in September Passenger Traffic
Ryanair Holdings PLC sees a 4% rise in September traffic, totaling over 20.1 million guests, despite operational challenges in the air transportation sector.
Acumen Pharmaceuticals reports Q3 results, updates pipeline
Acumen Pharmaceuticals, Inc. releases Q3 financial results, highlighting developments in its biological products pipeline and implications for the industry.
Ascendis Pharma reports breakthrough data on kidney function
Ascendis Pharma reveals new data on kidney function improvements for hypoparathyroidism treatment, potentially reshaping patient care in the pharmaceutical sector.
Martin Midstream Partners Reports Q3 Results, Shows Growth
Martin Midstream Partners L.P. releases Q3 results, indicating growth in its operations and a focus on improving efficiency in the wholesale petroleum sector.
Gorman Rupp Co. Reports Third Quarter Results for 2026
Gorman Rupp Co. announces its third-quarter results, showcasing resilience in the pumps and pumping equipment industry amid ongoing challenges.
ArcelorMittal discloses share transactions by Lumen Investments
ArcelorMittal reports share transactions by Lumen Investments, impacting transparency in shareholder activities within the steel industry.
Hestia Insight reports Q3 2026 results amid industry shifts
Hestia Insight Inc. releases its Q3 2026 financial results, reflecting ongoing operations in management consulting services.
Alexandria Real Estate Equities reports Q3 results
Alexandria Real Estate Equities, Inc. announces third-quarter results, highlighting growth in rental income and a robust balance sheet.
Graybar Electric reports third-quarter results for 2026
Graybar Electric Co. releases its Q3 2026 results, showcasing resilience in the wholesale electrical apparatus sector amidst competitive challenges.
FirstCash Holdings reports Q3 results, highlights growth plans
FirstCash Holdings, Inc. files Q3 report, showcasing growth strategies in the retail sector. The update signals ongoing expansion and competitive positioning.
Green Circle Decarbonize Technology Responds to Trading Inquiry
Green Circle Decarbonize Technology Ltd addresses unusual trading activity in its shares, confirming no undisclosed developments affecting operations.
Deep Sea Minerals Corp. launches U.S. public offering
Deep Sea Minerals Corp. announces a public offering of American depositary shares and warrants, aiming for a U.S. listing to support its exploration efforts.
SEI Investments reports stable Q3 results amid market challenges
SEI Investments Co. reports stable Q3 results, reflecting ongoing trends in the security brokerage sector. Competitors may need to reassess strategies.
GSK Reports Phase III Trial Success for Osteosarcoma Drug
GSK plc announces positive phase III trial results for Ris-Rez in treating relapsed osteosarcoma, showing a 67% reduction in disease progression.